Brilinta 60 Tablet: A Comprehensive Description of Ticagrelor 60mg
Ticagrelor 60 mg is the active component that may be found in one tablet of the drug known as Brilinta 60. Platelet inhibitors or antiplatelet agents are the category of medicines that this substance falls within. The primary purpose of the Brilinta 60 Tablet is to reduce the risk of blood clots developing in patients who have recently suffered from a heart attack or severe chest pain (acute coronary syndrome). It does this by stopping the platelets in the blood from adhering to one another and creating clots, which in turn helps to lower the risk of subsequent cardiovascular events. Oral tablets of Brilinta 60 are available and should be taken exactly as recommended by a physician or other qualified healthcare professional.
How Does Brilinta 60 Tablet Work?
Ticagrelor, the active component of Brilinta 60 Tablet, is responsible for the therapeutic effects of the medication. It achieves its effect by inhibiting the activity of a particular receptor on platelets known as the P2Y12 receptor. Ticagrelor works to stop platelets from clumping together and creating blood clots by blocking a specific receptor on platelets. This technique serves to maintain blood flow through the blood vessels, hence minimising the risk of cardiovascular events such as heart attacks and strokes.
Indications for Brilinta 60 Tablet
The use of Brilinta 60 Tablet is recommended for the treatment of the following conditions:
Acute coronary syndrome, often known as ACS, is a phrase that is used to describe a spectrum of disorders that result from diminished blood supply to the heart. Some examples of these conditions are unstable angina and heart attacks. As part of the treatment for acute coronary syndrome (ACS), the Brilinta 60 Tablet is used to lower the risk of cardiovascular events and prevent new blood clots from forming.
Dosage and Administration
It is important to take Brilinta 60 Tablet exactly as directed by your doctor or other healthcare provider. It is possible for the dosage to change depending on the characteristics of the individual patient as well as the illness that is being treated. It is recommended that the tablet be taken with a full glass of water, regardless of whether it is taken with or without food. It is essential to take the medication exactly as directed by the healthcare professional and to strictly adhere to the dosage that has been provided.
Related Product
Brilinta 60 Tablet
Brilinta 90 Tablet
Possible Side Effects
Brilinta 60 Tablet, like any other medicine, has the potential to cause a variety of unwanted side effects. Ticagrelor is known to cause a variety of common adverse effects, including:
- Bleeding is a side effect that can occur as a result of taking ticagrelor, and it can present itself in a variety of ways, including nosebleeds, bruises, or persistent bleeding from cuts. There is a possibility that you could experience significant bleeding, which would require medical assistance.
- Breathing difficulties or shortness of breath: While using Brilinta 60 Tablet, some people may suffer difficulty breathing or shortness of breath. In the event that this takes place, it is essential to seek medical attention as soon as possible.
- Headache: Mild to moderate headaches may occur in some individuals.
It is essential to keep in mind that these negative consequences do not occur in every single person, and the degree to which they manifest varies depending on the individual experiencing them. It is recommended that you speak with a medical expert in the event that any of these adverse effects continue or become worse.
Drug Interactions
Brilinta 60 Tablet may interact with some medications that increase the risk of bleeding, such as anticoagulants (e.g., warfarin) and nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin or ibuprofen. These medications include anticoagulants (e.g., warfarin) and nonsteroidal anti-inflammatory drugs (NSAIDs). It is imperative that you inform your healthcare practitioner about all of the drugs that you are currently taking in order to guarantee safe coadministration and to prevent excessive bleeding.
Inhibitors and inducers of the CYP3A4 enzyme The enzyme CYP3A4 in the liver is responsible for the metabolism of ticagrelor, which is the active ingredient in Brilinta 60 Tablet. Ticagrelor levels in the body can be influenced by medications that either inhibit or promote the action of this enzyme. It is imperative that you inform your healthcare practitioner about any and all medications you are currently taking, including prescription prescriptions, over-the-counter medications, and herbal supplements, in order to prevent any potential adverse reactions from occurring due to drug interactions.
Precautions and Warnings
- Allergic reactions: The active ingredient ticagrelor or one of the other components of Brilinta 60 Tablet could cause hypersensitivity in certain people. Seek immediate medical treatment if you suffer symptoms of an allergic response, such as a rash, itching, swelling, or difficulty breathing, as these could all indicate an allergic reaction.
- It is imperative that you let your healthcare practitioner know that you are taking Brilinta 60 Tablet if you are planning on undergoing any kind of dental or surgical procedure while you are using this medication. They may recommend that you temporarily stop taking the medication in order to reduce the likelihood that you will experience heavy bleeding during the surgery.
- pregnant and breastfeeding: It has not been determined whether or not Brilinta 60 Tablet is safe to take during pregnant or while breastfeeding. If you are pregnant, breastfeeding, or have plans to become pregnant in the near future, it is critical that you have a conversation with your healthcare practitioner about the potential dangers and benefits of the medicine.
- Brilinta Discontinuation: It is possible that the risk of cardiovascular events will increase if you stop taking Brilinta 60 Tablet all of a sudden. Should it become necessary for you to stop taking the medicine, your healthcare professional will walk you through the steps necessary to make a smooth transition to an alternative form of treatment.
Conclusion
Brilinta 60 Tablet is a drug that is intended to prevent blood clots and lower the risk of cardiovascular events in patients who have been diagnosed with acute coronary syndrome. Each tablet contains 60 milligrammes of ticagrelor. Brilinta 60 Tablet works to minimise the risk of having a heart attack or stroke by preventing the aggregation of platelets. This helps to keep blood flowing freely through the body’s blood vessels. It is essential to take the medication exactly as directed, be aware of any potential adverse effects, and discuss any concerns you may have with a qualified medical expert. In your particular circumstance, the use of Brilinta 60 Tablet in a safe and effective manner will require routine monitoring as well as follow-up appointments.
